The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome

RUNX3 is believed to have tumour suppressor properties in several cancer types. Inactivation of RUNX3 has been shown to occur by methylation-induced transcriptional silencing and by mislocalization of the protein to the cytoplasm. The aim of this study was to examine the clinical significance of RUN...

Descripción completa

Detalles Bibliográficos
Autores principales: Soong, R, Shah, N, Peh, B K, Chong, P Y, Ng, S S, Zeps, N, Joseph, D, Salto-Tellez, M, Iacopetta, B, Ito, Y
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653772/
https://www.ncbi.nlm.nih.gov/pubmed/19223906
http://dx.doi.org/10.1038/sj.bjc.6604899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653772/
https://www.ncbi.nlm.nih.gov/pubmed/19223906
http://dx.doi.org/10.1038/sj.bjc.6604899

Ejemplares similares